Scrutinizer''s Report
Awaiting price reaction for this filing.
Murae Organisor Limited (formerly Earum Pharmaceuticals) conducted a Postal Ballot through remote e-voting that closed on May 29, 2025. Two resolutions were passed: (1) a Special Resolution approving a stock split sub-dividing every 1 equity share of face value Rs. 2 into 2 equity shares of face value Re. 1 each, and (2) an Ordinary Resolution to alter the Capital Clause of the Memorandum of Association to reflect the new face value. Out of 80,856 members, 98 cast votes via e-voting. For the stock split, 209.35 million shares were polled (22.52% of outstanding), with 99.98% votes in favour and just 0.02% against. For the capital alteration, 99.999% of polled shares voted in favour. The authorised share capital will remain at Rs. 190 crore but will be divided into 190 crore shares of Rs. 1 face value each.
Each shareholder will receive 2 shares of Re. 1 face value for every 1 share of Rs. 2 face value held, effectively doubling share count while proportionally reducing per-share price — total investment value remains unchanged, but lower per-share price typically improves liquidity and retail accessibility. Promoter and Promoter Group held zero shares and did not participate in the voting, which is notable.